Francesca Arruga

2.7k total citations
60 papers, 1.3k citations indexed

About

Francesca Arruga is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Francesca Arruga has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 28 papers in Molecular Biology and 21 papers in Hematology. Recurrent topics in Francesca Arruga's work include Chronic Lymphocytic Leukemia Research (27 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Acute Myeloid Leukemia Research (10 papers). Francesca Arruga is often cited by papers focused on Chronic Lymphocytic Leukemia Research (27 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Acute Myeloid Leukemia Research (10 papers). Francesca Arruga collaborates with scholars based in Italy, United States and United Kingdom. Francesca Arruga's co-authors include Silvia Deaglio, Tiziana Vaisitti, Giuseppe Saglio, Emanuela Messa, Daniela Cilloni, Nicoletta Vitale, F. Messa, Sara Serra, Sonia Carturan and Ilaria Defilippi and has published in prestigious journals such as Blood, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Francesca Arruga

55 papers receiving 1.3k citations

Peers

Countries citing papers authored by Francesca Arruga

Since Specialization

Citations

This map shows the geographic impact of Francesca Arruga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Arruga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Arruga more than expected).

Fields of papers citing papers by Francesca Arruga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Arruga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Arruga. The network helps show where Francesca Arruga may publish in the future.

Co-authorship network of co-authors of Francesca Arruga

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Arruga. A scholar is included among the top collaborators of Francesca Arruga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Arruga. Francesca Arruga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic and Transcriptomic Profile of HNF1A-Mutated Liver Adenomas Highlights Molecular Signature and Potential Therapeutic Implications 2024 ·International Journal of Molecular Sciences ·Angelo Corso Faini, Francesca Arruga, Michele Pinon, (unknown), (unknown), (unknown), (unknown), (unknown), Alessandro Gambella, (unknown), (unknown), Paola Cassoni, (unknown), Renato Romagnoli, Antonio Amoroso, Pier Luigi Calvo, Tiziana Vaisitti, Silvia Deaglio	0
2	Matching clinical and genetic data in pediatric patients at risk of developing cystic kidney disease 2024 ·Pediatric Nephrology ·(unknown), Tiziana Vaisitti, (unknown), Angelo Corso Faini, (unknown), (unknown), Roberta Camilla, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Francesca Arruga, Diana Carli, Antonio Amoroso, (unknown), Silvia Deaglio, Licia Peruzzi	0
3	The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy 2023 ·Haematologica ·Francesca Arruga, (unknown), (unknown), Andrea Iannello, Nikolaos Ioannou, Riccardo Moia, Davide Rossi, Gianluca Gaïdano, Marta Coscia, Luca Laurenti, Giovanni D’Arena, John N. Allan, Richard R. Furman, Tiziana Vaisitti, Alan G. Ramsay, Silvia Deaglio	7
4	Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia 2023 ·Scientific Reports ·Candida Vitale, Valentina Griggio, Maria Chiara Todaro, Chiara Riganti, Rebecca Jones, (unknown), (unknown), Francesca Arruga, Tiziana Vaisitti, Dimitar G. Efremov, Silvia Deaglio, Yosef Landesman, Benedetto Bruno, Marta Coscia	2
5	HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study 2021 ·The Journal of Heart and Lung Transplantation ·(unknown), Gabriele Togliatto, (unknown), Massimo Boffini, (unknown), Alessandro Gambella, Francesca Arruga, (unknown), Matteo Marro, (unknown), (unknown), Paola Magistroni, Luisa Delsedime, Mauro Papotti, Antonio Amoroso, Mauro Rinaldi, Tiziana Vaisitti, Silvia Deaglio	15
6	CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance 2020 ·Frontiers in Oncology ·Giovanni D’Arena, Vincenzo De Feo, Giuseppe Pietrantuono, Elisa Seneca, Giovanna Mansueto, Oreste Villani, Francesco La Rocca, Fiorella D’Auria, Teodora Statuto, (unknown), Francesca Arruga, Silvia Deaglio, Dimitar G. Efremov, Alessandro Sgambato, Luca Laurenti	20
7	HaTSPiL: A modular pipeline for high-throughput sequencing data analysis 2019 ·PLoS ONE ·Edoardo Morandi, Matteo Cereda, Danny Incarnato, Caterina Parlato, Giulia Basile, Francesca Anselmi, (unknown), (unknown), (unknown), Francesca Arruga, Silvia Deaglio, Elisa Tirtei, Franca Fagioli, Salvatore Oliviero	3
8	Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets 2019 ·Frontiers in Immunology ·Tiziana Vaisitti, Francesca Arruga, (unknown), Silvia Deaglio	26
9	Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses 2018 ·Cancer Research ·Tiziana Vaisitti, Esteban Braggio, John N. Allan, Francesca Arruga, Sara Serra, Alberto Zamò, Wayne Tam, Amy Chadburn, Richard R. Furman, Silvia Deaglio	33
10	Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor 2017 ·Haematologica ·Tiziana Vaisitti, Federica Gaudino, Samedy Ouk, (unknown), Nicoletta Vitale, Sara Serra, Francesca Arruga, Johannes L. Zakrzewski, Hsiou‐Chi Liou, John N. Allan, Richard R. Furman, Silvia Deaglio	35
11	Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia 2017 ·Handbook of experimental pharmacology ·Francesca Arruga, Silvia Deaglio	7
12	Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia 2014 ·Blood ·Valentina Audrito, Sara Serra, Davide Brusa, Francesca Mazzola, Francesca Arruga, Tiziana Vaisitti, Marta Coscia, Rossana Maffei, Davide Rossi, Tao Wang, Giorgio Inghirami, Menico Rizzi, Gianluca Gaïdano, Joe G. N. Garcia, Cynthia Wolberger, Nadia Raffaelli, Silvia Deaglio	154
13	Deferasirox is a powerful NF- B inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging 2010 ·Haematologica ·Emanuela Messa, Sonia Carturan, (unknown), Marisa Pautasso, Enrico Bracco, Antonella Roetto, F. Messa, Francesca Arruga, Ilaria Defilippi, Valentina Rosso, (unknown), Antonia Rotolo, E. Greco, Rosa Maria Pellegrino, D. Alberti, Giuseppe Saglio, Daniela Cilloni	116
14	Detection of Humoral Immune Responses against WT1 Antigen in Patients Affected by Different Hematological Malignancies 2008 ·Acta Haematologica ·(unknown), Ilaria Defilippi, Sonia Carturan, Antonella Roetto, Francesca Messa, Francesca Arruga, Emanuela Messa, Antonia Rotolo, Ilaria Iacobucci, Enrico Bracco, Giuseppe Saglio, Daniela Cilloni	1
15	Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy 2008 ·Haematologica ·Daniela Cilloni, F. Messa, Francesca Arruga, Ilaria Defilippi, Enrico Gottardi, Milena Fava, Sonia Carturan, (unknown), Enrico Bracco, Emanuela Messa, (unknown), Daniela Diverio, Miguel Á. Sanz, Giovanni Martinelli, Francesco Lo‐Coco, Giuseppe Saglio	80
16	NF‐kB inhibition as a strategy to enhance etoposide‐induced apoptosis in K562 cell line 2006 ·American Journal of Hematology ·Alessandro Morotti, Daniela Cilloni, Marisa Pautasso, F. Messa, Francesca Arruga, Ilaria Defilippi, Sonia Carturan, (unknown), Valentina Rosso, Annalisa Chiarenza, Riccardo Taulli, Enrico Bracco, Giovanna Rege‐Cambrin, Enrico Gottardi, Giuseppe Saglio	37
17	Valproate enhances imatinib‐induced growth arrest and apoptosis in chronic myeloid leukemia cells 2006 ·Cancer ·Alessandro Morotti, Daniela Cilloni, Francesca Messa, Francesca Arruga, Ilaria Defilippi, Sonia Carturan, (unknown), Valentina Rosso, Annalisa Chiarenza, (unknown), Angelo Guerrasio, Riccardo Taulli, Enrico Bracco, Marisa Pautasso, (unknown), Enrico Gottardi, Giuseppe Saglio	30
18	Genetic Abnormalities as Targets for Molecular Therapies in Myelodysplastic Syndromes 2006 ·Annals of the New York Academy of Sciences ·Daniela Cilloni, Emanuela Messa, Francesca Messa, Sonia Carturan, Ilaria Defilippi, Francesca Arruga, Valentina Rosso, (unknown), Enrico Bracco, (unknown), Giuseppe Saglio	7
19	Myelodysplastic Syndromes 2004 ·Annals of the New York Academy of Sciences ·(unknown), Francesca Messa, Sonia Carturan, Francesca Arruga, Ilaria Defilippi, Emanuela Messa, Enrico Gottardi, Giuseppe Saglio	5
20	Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation 2004 ·Cancer ·Daniela Cilloni, Francesca Messa, Enrico Gottardi, Milena Fava, Francesca Arruga, Ilaria Defilippi, Sonia Carturan, Emanuela Messa, Alessandro Morotti, Emilia Giugliano, Giovanna Rege‐Cambrin, Daniele Alberti, Michele Baccarani, Giuseppe Saglio	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact